Fortrex™ A35HPV06100080 (UDI 00763000106041)Recalls & reported problems
Covidien LP · PTA A35HPV06100080 FORTREX V02 · Class 2
All models of Fortrex (34)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00763000106041), received between Aug 11, 2021 and Jan 3, 2024 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Burst Container or Vessel1
- Inflation Problem1
- Material Twisted/Bent1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Thrombosis/Thrombus2
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJan 3, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING INDEX PROCEDURE A ELLIPSYS CATHETER WAS USED TO TREAT A LESION LOCATED IN THE LEFT ARM AND TWO FORTREX BALLOONS DURING THE SECONDARY PROCEDURE. APPROXIMATELY 5 MONTHS POST INDEX PROCEDURE PATIENT SUFFERED A CLOTTED AV FISTULA. THE PATIENT WAS TREATED WITH PERCUTANEOUS INTERVENTION. PATIENT RECOVERED.
Patient problems: Thrombosis/Thrombus
MAUDE report 18433841 ↗InjuryJan 3, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING INDEX PROCEDURE A ELLIPSYS CATHETER WAS USED TO TREAT A LESION LOCATED IN THE LEFT ARM AND TWO FORTREX BALLOONS DURING THE SECONDARY PROCEDURE. APPROXIMATELY 5 MONTHS POST INDEX PROCEDURE PATIENT SUFFERED A CLOTTED AV FISTULA. THE PATIENT WAS TREATED WITH PERCUTANEOUS INTERVENTION. PATIENT RECOVERED.
Patient problems: Thrombosis/Thrombus
MAUDE report 18433837 ↗MalfunctionDec 14, 2021Inflation Problem; Material Twisted/Bent; Inflation Problem; Material Twisted/Bent
PHYSICIAN ATTEMPTED TO USE AN FORTREX HP PTA BALLOON CATHETER DURING PATIENT TREATMENT. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. NO ISSUES WERE NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. AN INFLATION DEVICE WAS USED FOR BALLOON INFLATION. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS NOTED DURING ADVANCEMENT. IT IS REPORTED BALLOON INFLATION DIFFICULTIES OCCURRED WHEN DEVICE WAS INFLATED TO NOMINAL BURST PRESSURE. THERE WAS NO LEAK NOTED IN THE DEVICE. THE BALLOON DID NOT BURST. THE DEVICE WAS SAFELY REMOVED FROM THE PATIENT. A NEW FORTREX DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13003890 ↗MalfunctionAug 11, 2021Burst Container or Vessel; Burst Container or Vessel
PHYSICIAN WAS ATTEMPTING TO USE A FORTREX PTA BALLOON DURING PROCEDURE TO TREAT A MODERATELY CALCIFIED LESION IN THE PROXIMAL CENTRAL VENOUS FISTULA WITH 70% STENOSIS. THE VESSEL WAS MODERATELY TORTUOUS. THERE WAS NO DAMAGE NOTED TO THE PACKAGING AND NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE DEVICE WAS PREPPED AS PER IFU WITH NO ISSUES. THERE WAS NO RESISTANCE ENCOUNTERED WHEN ADVANCING THE DEVICE. IT WAS REPORTED THAT THE BALLOON BURST LONGITUDINALLY DURING ONE INFLATION AT 10 ATM. ALL FRAGMENTS OF THE BALLOON WERE RETRIEVED. THE PROCEDURE WAS COMPLETED BY USING ANOTHER BALLOON. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12306704 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page